| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.0096 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |